Triglav Investments D.O.O. Acquires 100 Shares of Intuitive Surgical, Inc. $ISRG

Triglav Investments D.O.O. raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.3% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,020 shares of the medical equipment provider’s stock after purchasing an additional 100 shares during the quarter. Triglav Investments D.O.O.’s holdings in Intuitive Surgical were worth $4,358,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently made changes to their positions in the company. Chilton Capital Management LLC increased its holdings in Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 43 shares during the last quarter. Elite Financial Inc. purchased a new position in Intuitive Surgical in the first quarter valued at about $26,000. TD Capital Management LLC grew its position in shares of Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after acquiring an additional 45 shares during the period. 1248 Management LLC purchased a new stake in shares of Intuitive Surgical during the 1st quarter worth approximately $30,000. Finally, Princeton Global Asset Management LLC purchased a new stake in shares of Intuitive Surgical during the 2nd quarter worth approximately $30,000. 83.64% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on ISRG shares. Truist Financial set a $620.00 price objective on Intuitive Surgical and gave the company a “buy” rating in a research note on Wednesday, October 22nd. Robert W. Baird set a $655.00 price target on Intuitive Surgical in a research report on Wednesday, October 22nd. Piper Sandler increased their price target on Intuitive Surgical from $595.00 to $610.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 22nd. Argus boosted their price objective on Intuitive Surgical from $600.00 to $630.00 in a research note on Monday, October 27th. Finally, Rothschild & Co Redburn upped their price objective on shares of Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $608.92.

Insider Transactions at Intuitive Surgical

In other news, EVP Myriam Curet sold 125 shares of the firm’s stock in a transaction that occurred on Wednesday, October 29th. The shares were sold at an average price of $543.00, for a total value of $67,875.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Gary S. Guthart sold 2,800 shares of the business’s stock in a transaction that occurred on Friday, October 24th. The shares were sold at an average price of $546.27, for a total transaction of $1,529,556.00. Following the transaction, the insider directly owned 17,120 shares of the company’s stock, valued at approximately $9,352,142.40. This represents a 14.06% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 96,011 shares of company stock valued at $50,309,042. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $534.28 on Friday. The business’s fifty day moving average is $464.32 and its 200 day moving average is $498.61. The firm has a market cap of $191.53 billion, a price-to-earnings ratio of 70.67, a PEG ratio of 4.94 and a beta of 1.61. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The business had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. During the same quarter last year, the company earned $1.84 EPS. The firm’s revenue was up 22.9% compared to the same quarter last year. Equities analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.